Last reviewed · How we verify

octenisept® — Competitive Intelligence Brief

octenisept® (octenisept®) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antiseptic/Antimicrobial solution. Area: Dermatology/Infection Prevention.

marketed Antiseptic/Antimicrobial solution Dermatology/Infection Prevention Small molecule Live · refreshed every 30 min

Target snapshot

octenisept® (octenisept®) — Schülke & Mayr GmbH. Octenisept is an antimicrobial solution that disrupts bacterial and fungal cell membranes through a combination of octenidine and phenoxyethanol, providing rapid broad-spectrum antiseptic activity.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
octenisept® TARGET octenisept® Schülke & Mayr GmbH marketed Antiseptic/Antimicrobial solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antiseptic/Antimicrobial solution class)

  1. Schülke & Mayr GmbH · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). octenisept® — Competitive Intelligence Brief. https://druglandscape.com/ci/octenisept. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: